Learn More


Contact Us Today


The Patent '813 Story*


      *U.S.  Patent No. 8,318,813 ("the '813 Patent") , invented by Louis Sanfilippo MD, 

       claims methods to treat Binge Eating Disorder With Lisdexamfetamine Dimesylate


​      ​​​​                           2014-2018 News & Milestones​​​​​

 

May 18, 2018 --  Porter F. Fleming, Haug Partners LLP, Files Appearance of Counsel for Shire LLC and Shire Development LLC (but not Shire Plc)

May 18, 2018 -- Letter from Haug Partners' Porter Fleming (counsel to Shire LLC and Shire Development LLC defendants) to U.S. District Judge Analisa Torres
 
May 15, 2018 -- Letter from Haug Partners' Porter Fleming (counsel to Shire LLC and Shire Development LLC defendants) to Foundation Law Group's Stephen Lobbin (counsel to Plaintiff LCS Group)
 
May 7, 2018  -- Letter from Foundation Law Group's Stephen Lobbin (counsel to Plaintiff LCS Group) to Haug Partners' Porter Fleming (counsel to Shire LLC and Shire Development LLC defendants)
 
May 1, 2018 -- Letter from Haug Partners' Porter Fleming (counsel to Shire LLC and Shire Development LLC Defendants) to Foundation Law Group's Stephen Lobbin (counsel to Plaintiff LCS Group) 
 
April 26, 2018 -- Letter from Haug Partners' Porter Fleming (counsel to Shire LLC and Shire Development LLC Defendants) to Foundation Law Group's Stephen Lobbin (counsel to Plaintiff LCS Group)
 
March 27, 2018 -- LCS Group, LLC v. Shire LLC, Shire Development LLC, and Shire PLC In the United States District Court for the Southern District of New York
 
October 24, 2017 --  Shire and its Outside Counsel Haug Partners Implicated in Massive Double Standard, Hypocrisy Related to Supreme Court Case and Amicus Brief​  

 

February 27, 2017 -- Vyvanse-for-BED Patent Lawsuit Takes Profile Deeper, to Shire’s Outside Counsel Frommer, Lawrence & Haug; Will There Be A Surprise Development in the Story? 

 

February 15, 2017 -- Dr. Louis Sanfilippo v. Dr. Timothy Brewerton “Vyvanse for BED Patent" Lawsuit Filed in Federal Court, Shire CEO Dr. Flemming Ornskov Informed. So Which Psychiatrist is Telling the Truth and Which Is Deceiving? You Can Be the Judge 

 

January 20, 2017 -- Louis Sanfilippo, M.D. v. Timothy Brewerton, M.D. Lawsuit Alleging Fraud, Negligence and Defamation Filed in U.S. District Court (South Carolina, Charleston Division

 

October 24, 2016  --  APS Holding Launches Web-Based Fraud Exposure Platform

 

​June 13, 2015 --  PTAB Invalidates Lucerne Biosciences' '813 Patent for the Treatment of Binge Eating Disorder with Lisdexamfetamine Dimesylate
 
January 30, 2015 -- Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) Becomes First and Only Treatment Approved by the FDA for Adults with Moderate to Severe Binge Eating Disorder
 
May 9, 2014 -- Shire Development LLC Files Inter Partes Review Petition Against LCS Group, LLC & U.S. Patent 8,318,813 in the Patent Trial & Appeal Board of the United States Patent & Trademark Office